+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

"Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation



"Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation



Arthritis and Rheumatism 44(2): 408-418



Objective. Many studies have shown that the microanatomic organization of infiltrating leukocytes in the salivary gland lesions of patients with Sjogren's syndrome (SS) resembles the structure of lymphoid organs. A newly defined set of chemokines referred to as "lymphoid," which orchestrate leukocyte microenvironmental homing and contribute to the formation of lymphoid structures, provides directional clues. The aim of this study was to investigate the possible existence of "lymphoid" chemokines in chronic inflammatory lesions of SS patients and thus validate their potential involvement in the disease process. Methods. Twelve patients with primary SS, 3 patients with secondary SS, 4 patients with other autoimmune disorders, and 4 control individuals were the subjects of this study. Reverse transcriptase-polymerase chain reaction analysis was performed in order to examine the messenger RNA (mRNA) expression of "lymphoid" chemokines. Furthermore, in situ hybridization studies revealed chemokine mRNA localization. Immunohistochemistry was also applied in order to identify the cell types that expressed the chemokine mRNA. Results. STCP-1/monocyte-derived chemokine and TARC mRNA were expressed in the majority of patients with primary and secondary SS, in 2 of 4 patients with other autoimmune disorders, and in 2 of 4 controls. BCA-1, ELC, and PARC mRNA were only detected in patients with primary and secondary SS. SLC mRNA was also detected in 1 non-SS patients. The main cellular sources of chemokine mRNA were ductal epithelial cells and infiltrating mononuclear leukocytes. Conclusions. The expression pattern of "lymphoid" chemokine mRNA points further to the role of epithelial cells in the pathogenesis of SS and offers new insight into the potential mechanisms that could be involved in leukocyte attraction and in the in situ formation of secondary lymphoid tissue structures.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045003576

Download citation: RISBibTeXText

PMID: 11229473

DOI: 10.1002/1529-0131(200102)44:2<408::aid-anr60>3.0.co;2-0


Related references

Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren's syndrome. Scandinavian Journal of Immunology 55(4): 336-342, 2002

Characterisation of follicular dendritic cells in labial salivary glands of patients with primary Sjogren syndrome: Comparison with tonsillar lymphoid follicles. Annals of the Rheumatic Diseases 56(2): 140-143, 1997

CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. Journal of Immunology 180(7): 5130-5140, 2008

Lymphoid chemokines CXCL13 and CCL21 are abnormaly upregulated in salivary glands of malt lymphomas in Sjogren's syndrome and associate with the histological organisation of the reactive and malignant components of the lymphoid proliferation. 2006

Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis. Arthritis and Rheumatology 69(10): 2038-2051, 2017

CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome. Rheumatology 53(4): 611-620, 2014

Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren's syndrome. Journal of Oral Pathology and Medicine 37(9): 515-521, 2008

Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Research and Therapy 6(5): R447-R456, 2004

Class II MHC antigen expression on epithelial cells of salivary glands from patients with Sjögren's syndrome. Clinical and Experimental Rheumatology 5(3): 199-203, 1987

Mucosa-associated lymphoid tissue lymphoma of the salivary glands occurring in patients affected by Sjögren's syndrome: report of 6 cases. Acta Haematologica 105(2): 83-88, 2001

Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. American Journal of Pathology 160(4): 1445-1455, 2002

Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells. Clinical and Experimental Rheumatology 36 Suppl 112(3): 31-40, 2017

Cytokine messenger RNA expression in the labial salivary glands of patients with Sjogren's syndrome. Arthritis & Rheumatism 39(8): 1376-1384, 1996

Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome. Arthritis and Rheumatology 67(4): 1074-1083, 2015

Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clinical and Experimental Immunology 124(1): 126-133, 2001